U.S. Stem Cell, Inc. financial data

Symbol
USRM on OTC
Industry
Services-Commercial Physical & Biological Research
Location
1560 Sawgrass Corporate Pkwy, 4 Th Floor, Sunrise, FL
State of incorporation
FL
Fiscal year end
December 31
Former names
BIOHEART, INC. (to 11/2/2015)
Latest financial report
10-K - Q4 2022 - Apr 14, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 0.85 % -60%
Quick Ratio 0.01 % -86.9%
Debt-to-equity -101 % +1.19%
Return On Equity 20.4 % -25.5%
Return On Assets -2.52K % -86.4%
Operating Margin -2.1K % -97.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 642M shares +12.2%
Common Stock, Shares, Outstanding 634M shares +26%
Entity Public Float 2.38M USD 0%
Common Stock, Value, Issued 634K USD +26%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 82K USD -59.1%
Operating Income (Loss) -1.72M USD +19.4%
Nonoperating Income (Expense) -1.14M USD +1.22%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.86M USD +13.1%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -2.86M USD +13.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.13K USD -87%
Accounts Receivable, after Allowance for Credit Loss, Current 4.33K USD +257%
Inventory, Net 980 USD +149%
Assets, Current 68K USD +33.4%
Assets 68K USD +33.4%
Accounts Payable, Current 1.62M USD +18.3%
Accrued Liabilities, Current 2.58M USD +32.3%
Liabilities, Current 14.1M USD +16.9%
Liabilities 14.8M USD +15.6%
Retained Earnings (Accumulated Deficit) -143M USD -1.94%
Stockholders' Equity Attributable to Parent -14.7M USD -15.5%
Liabilities and Equity 68K USD +33.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -63.8K USD +79.9%
Net Cash Provided by (Used in) Financing Activities 38.9K USD -94.8%
Common Stock, Shares Authorized 2B shares 0%
Common Stock, Shares, Issued 634M shares +26%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.13K USD -87%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5.38K USD -31%
Deferred Tax Assets, Valuation Allowance 26.4M USD -5.46%
Deferred Tax Assets, Gross 26.4M USD -5.67%
Deferred Tax Assets, Operating Loss Carryforwards 20.2M USD -8.82%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Additional Paid in Capital 127M USD +0.48%
Preferred Stock, Shares Outstanding 0 shares
Interest Expense 690K USD -31%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%